SCHEMBL8356609

SCHEMBL8356609

N/C(=N\O)c1ccc(CNC(=O)CNC(=O)[C@@H](Cc2cccc(/C(N)=N\O)c2)NS(=O)(=O)Cc2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 13/20 0.49
▸ F10 P00742 12/20 0.49
▸ PLG P00747 4/20 0.48
▸ KLKB1 P03952 2/20 0.48
▸ PROC P04070 1/20 0.48
▸ TMPRSS6 Q8IU80 4/20 0.46
▸ TMPRSS11D O60235 4/20 0.42
▸ PRSS1 P07477 1/20 0.42
▸ PRSS2 P07478 1/20 0.42
▸ PRSS3 P35030 1/20 0.42
▸ F11 P03951 1/20 0.41
▸ ITGB3 P05106 1/20 0.39
▸ ITGAV P06756 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8358388 0.88 F2 (0.59) F2F10PLGKLKB1PROC
SCHEMBL12156653 0.82 F2 (0.61) F2F10PLGKLKB1PROC
SCHEMBL8346530 0.77 F2 (0.57) F2F10PLGTMPRSS6TMPRSS11D
SCHEMBL8290804 0.77 F2 (0.52) F2F10PLGKLKB1PROC
SCHEMBL8344650 0.76 F2 (0.56) F2F10PLGKLKB1PROC
SCHEMBL8291002 0.75 F10 (0.56) F2F10PLGKLKB1PROC
SCHEMBL8291001 0.75 F10 (0.56) F2F10PLGKLKB1PROC
SCHEMBL8221418 0.75 F10 (0.52) F2F10PLGKLKB1PROC
SCHEMBL15080624 0.75 F10 (0.42) F2F10PLGTMPRSS11DPRSS1
SCHEMBL17366097 0.74 F2 (0.49) F2F10PLGKLKB1PROC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1483285-B1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME CURACYTE AG (DE) 2008-05-07 — — EP disclosed
WO-2003076457-A1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME CURACYTE AG (DE) 2003-09-18 — — WO disclosed
Send feedback